Insider filing · BBIO
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
KKR Group Holdings Corp. sold $197.8M of BridgeBio Pharma (BBIO)
Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.
Value, as filed
$197.8M
6,000,000 sh × $32.96
Executed
Mar 5 2025
the trade date, as filed
Disclosed
Mar 7 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KC
KKR Group Holdings Corp.
10% owner
profile →
KKR Group Holdings Corp. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $197.8M of BBIO (6,000,000 sh × $32.96, as filed), executed Mar 5 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→